Close

Mirati Therapeutics (MRTX) seen worth more than double in a buyout

Go back to Mirati Therapeutics (MRTX) seen worth more than double in a buyout

4 Rumors Buzzing Around Wall Street Today

November 22, 2022 4:17 PM EST

Stocks closed solidly higher Tuesday as strong earnings from retailers, including Best Buy, allayed concerns that the consumer is weak into the holiday season. Amid the upside, several rumors swirled around the Street. Below we highlighted a few:

Mirati Therapeutics (NASDAQ:... More

Mirati Therapeutics (MRTX) Halted on Volatility

November 22, 2022 3:04 PM EST

Mirati Therapeutics (NASDAQ: MRTX) Halted on Volatility

... More

Mirati Therapeutics (MRTX) Said to Draw Fresh Takeover Interest - Bloomberg

November 22, 2022 3:03 PM EST

(Updated - November 22, 2022 3:06 PM EST)

Mirati Therapeutics (NASDAQ: MRTX) is attracting fresh takeover interest from large pharma companies ahead of updates on its drug pipeline, according to Bloomberg, citing people with knowledge of the matter.

Mirati is working with an... More